These inhibitors primarily target the SMO protein, preventing it from activating the downstream signaling cascade. By blocking SMO, the inhibitors prevent the activation of Gli transcription factors, thereby reducing the expression of genes that promote cell growth and survival. This effectively inhibits the proliferation of cancer cells that rely on Hedgehog pathway signaling.
